A recent analysis using data from the U.S. Multicenter HCC Transplant Consortium showed that in LT patients with HCC presenting beyond the Milan criteria, successful downstaging predicted by the response of alpha-fetoprotein to locoregional therapy and tumor burden led to excellent post-LT outcomes, compared to patients without downstaging [41]. The gene discussed is AFP; the disease is neoplasm.